Our Event Partners:
Natera | Expertise Partner
Natera supports personalized kidney care and drug development through advanced genetic testing and insights. Powered by the Renasight™ gene panel, RenasightIQ™ gives pharma partners access to a clinicogenomic database of 150,000+ patients, paired with longitudinal data. This enables real-world insights across the drug development lifecycle.
MediBeacon | Exhibition Partner
MediBeacon’s use of fluorescent tracer agents coupled with transdermal detection technology focuses on providing vital and actionable organ function measurement.
The Transdermal GFR Measurement System Pivotal study (NCT05425719) was completed in 2023. The phase 3 study met pre-negotiated primary and secondary endpoints.
MediBeacon Transdermal measurement of Glomerular Filtration Rate (tGFR) is being shown to have many preclinical nephrology applications with over 500 peer-reviewed publications and conference abstracts in which Transdermal GFR (tGFR) has been used.
